Information för alternativet: Avestra 75 Mg Filmdragerad Tablett, visar 2 alternativ

Package leaflet: Information for the patient

Avestra 75 mg film-coated tablets

risedronate sodium

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

What is in this leaflet

1. What Avestra is and what it is used for

2. What you need to know before you take Avestra

3. How to take Avestra

4. Possible side effects

5. How to store Avestra

6. Contents of the pack and other information

1. What Avestra is and what it is used for

What Avestra is

Avestra belongs to a group of non-hormonal medicines called bisphosphonates which are used to treat bone diseases. It works directly on your bones to make them stronger and therefore less likely to break.

Bone is a living tissue. Old bone is constantly removed from your skeleton and replaced with new bone.

Postmenopausal osteoporosis is a condition occurring in women after the menopause where the bones become weaker, more fragile and more likely to break after a fall or strain.

The spine, hip and wrist are the most likely bones to break, although this can happen to any bone in your body. Osteoporosis-related fractures can also cause back pain, height loss and a curved back. Many patients with osteoporosis have no symptoms and you may not even have known that you had it.

What Avestra is used for

The treatment of osteoporosis in postmenopausal women.

2. What you need to know before you take Avestra

Do not take Avestra

Warnings and precautions

Talk to your doctor or pharmacist before taking Avestra:

If you are unable to stay in an upright position (sitting or standing) for at least 30 minutes.

If you have abnormal bone and mineral metabolism (for example lack of vitamin D, parathyroid hormone abnormalities, both leading to a low blood calcium level).

If you have or have had problems in the past with your oesophagus (the tube that connects your mouth with your stomach). For instance you may have or have had pain or difficulty in swallowing foodor you have previously been told that you have Barrett's oesophagus (a condition associated with changes in the cells that line the lower oesophagus).

If you have had or have pain, swelling or numbness of the jaw or a “heavy jaw feeling” or loosening of a tooth.

If you are under dental treatment or will undergo dental surgery, tell your dentist that you are being treated with Avestra.

Your doctor will advise you on what to do when taking Avestra if you have any of the above.

Children and adolescents

Risedronate sodium is not recommended for use in children below age 18 due to insufficient data on safety and efficacy.

Other medicines and Avestra

Medicines containing one of the following lessen the effect of Avestra if taken at the same time:

Take these medicines at least 30 minutes after your Avestra tablet.

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Avestra with food and drink

It is very important that you do NOT take your Avestra tablet with food or drinks (other than plain water) so that it can work properly. In particular do not take this medicine at the same time as dairy products (such as milk) as they contain calcium (see section 2, “Other medicines and Avestra”).

Take food and drinks (other than plain water) at least 30 minutes after your Avestra tablet.

Pregnancy and breast-feeding

Do NOT take Avestra if you may be pregnant, are pregnant or planning to become pregnant (see section 2, “Do not take Avestra”). The potential risk associated with the use of risedronate sodium (active substance in Avestra) in pregnant women is unknown.

Do NOT take Avestra if you are breast-feeding (see section 2, “Do not take Avestra”).

Avestra should only be used to treat postmenopausal women.

Driving and using machines

Avestra is not known to affect your ability to drive and use machines.

3. How to take Avestra

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Recommended dose:

Avestra tablets should be taken on the SAME two consecutive dates each month, e.g. on the 1stand 2ndof the month, or the 15thand 16th.

Choose TWO dates in a row that best fit your schedule to take your Avestra. Take ONE Avestra tablet in the morning of your first chosen date. Take the SECOND tablet in the morning of the following day.

Repeat every month keeping the same two consecutive dates.To help you remember when to take your tablets next, you can mark your calendar ahead of time with a pen or stickers.

WHEN to take the Avestra tablet

Take your Avestra tablet at least 30 minutes before the first food, drink (other than plain water) or other medicine of the day.

HOW to take the Avestra tablet

Your doctor will tell you if you need calcium and vitamin supplements, if you are not taking enough from your diet.

If you take more Avestra than you should

If you or somebody else has accidentally taken more Avestra tablets than prescribed, drink one full glass of milkand seek medical attention.

If you forget to take Avestra

You forgot


What to do

1st and 2nd tablets

Next monthly dose is more than 7 days ahead

Take 1st tablet the next morning and 2nd tablet the morning of the following day

Next monthly dose is within 7 days

Do not take the tablets you have forgotten

2nd tablet only

Next monthly dose is more than 7 days ahead

Take 2nd tablet the next morning

Next monthly dose is within 7 days

Do not take the tablet you have forgotten

The next month, take your tablets again as usual.

In any case:

If you miss your dose of Avestra in the morning, do NOT take it later in the day.

Do NOT take three tablets within the same week.

If you stop taking Avestra

If you stop treatment you may begin to lose bone mass. Please talk to your doctor before you consider stopping treatment.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking Avestra and contact a doctor immediatelyif you experience any of the following:

Tell your doctor promptlyif you experience the following side effects:

Unusual fracture of the thigh bone particularly in patients on long-term treatment for osteoporosis may occur rarely. Contact your doctor if you experience pain, weakness or discomfort in your thigh, hip or groin as this may be an early indication of a possible fracture of the thigh bone.

However in clinical studies the other side effects that were observed were usually mild and did not cause the patient to stop taking their tablets.

Common side effects (may affect up to 1 in 10 people)

Uncommon side effects (may affect up to 1 in 100 people)

Rare side effects (may affect up to 1 in 1,000 people)

During post-marketing experience, the following have been reported

Rarely, at the beginning of treatment, a patient’s blood calcium and phosphate levels may fall. These changes are usually small and cause no symptoms.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.You can also report side effects directly via the national reporting system listed in Appendix V*. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Avestra

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Avestra contains

The active substance is risedronate sodium. Each tablet contains 75 mg risedronate sodium, equivalent to 69.6 mg risedronic acid.

The other ingredients are:

Tablet core: cellulose microcrystalline, crospovidone A and magnesium stearate.

Film coating:hypromellose, macrogol 400, macrogol 8000, hydroxypropylcellulose, colloidal anhydrous silica, titanium dioxide [E171], iron oxide red [E172].

What Avestra looks like and contents of the pack

Avestra 75 mg film-coated tablets are oval pink 11.7 x 5.8 mm tablets with the letters “RSN” on one side and “75 mg” on the other side. The tablets are supplied in blister packs of 2, 4, 6 or 8 tablets. Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

[To be completed nationally]


Warner Chilcott Deutschland GmbH,

Dr.-Otto-Röhm-Str. 2-4,

64331 Weiterstadt, Germany

This medicinal product is authorised in the Member States of the EEA under the following names:

Italy: Optinate 75 mg compresse rivestite con film

Sweden: Avestra 75 mg filmdragerade tabletter

This leaflet was last revised in

14 January 2016